Selected article for: "ARDS respiratory distress syndrome and influenza virus"
Author: You, Huey-Ling; Chen, Chung-Jen; Eng, Hock-Liew; Liao, Pei-Lin; Huang, Sheng-Teng
Title: The Effectiveness and Mechanism of Toona sinensis Extract Inhibit Attachment of Pandemic Influenza A (H1N1) Virus
  • Cord-id: 7a1vzf5p
  • Document date: 2013_9_2
    • ID: 7a1vzf5p
    Snippet: TSL-1 is a fraction of the aqueous extract from the tender leaf of Toona sinensis Roem, a nutritious vegetable. The pandemic influenza A (H1N1) virus is a recently described, rapidly contagious respiratory pathogen which can cause acute respiratory distress syndrome (ARDS) and poses a major public health threat. In this study, we found that TSL-1 inhibited viral yields on MDCK plaque formation by pandemic influenza A (H1N1) virus on infected A549 cells with high selectivity index. Meanwhile, TSL
    Document: TSL-1 is a fraction of the aqueous extract from the tender leaf of Toona sinensis Roem, a nutritious vegetable. The pandemic influenza A (H1N1) virus is a recently described, rapidly contagious respiratory pathogen which can cause acute respiratory distress syndrome (ARDS) and poses a major public health threat. In this study, we found that TSL-1 inhibited viral yields on MDCK plaque formation by pandemic influenza A (H1N1) virus on infected A549 cells with high selectivity index. Meanwhile, TSL-1 also suppressed viral genome loads in infected A549 cells, quantified by qRT-PCR. This study further demonstrated that TSL-1 inhibited pandemic influenza A (H1N1) virus activity through preventing attachment of A549 cells but not penetration. TSL-1 inhibited viral attachment through significant downregulation of adhesion molecules and chemokines (VCAM-1, ICAM-1, E-selectin, IL-8, and fractalkine) compared to Amantadine. Our results suggest that TSL-1 may be used as an alternative treatment and prophylaxis against pandemic influenza A (H1N1) virus.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute lung injury: 1, 2, 3
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and adhesion molecule: 1, 2, 3, 4
    • absence presence and adhesion molecule expression: 1
    • absence presence and low melting: 1
    • absence presence and low melting agarose: 1
    • absolute quantification and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute lung injury and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8
    • acute lung injury and adhesion molecule expression: 1, 2
    • acute respiratory syndrome and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adhesion molecule expression: 1, 2, 3, 4, 5